AEMD Aethlon Medical Inc
- Stocks
- Healthcare
- NASDAQ: AEMD
Price (delayed)
$1.33
Market cap
$3.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$8.58
Enterprise value
-$1.54M
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier
Highlights
Aethlon Medical's EPS has surged by 78% YoY and by 32% QoQ
The company's debt fell by 31% YoY and by 10% QoQ
The company's equity rose by 18% QoQ but it fell by 11% YoY
The quick ratio has grown by 6% from the previous quarter but it has contracted by 2.3% YoY
The net income has declined by 40% since the previous quarter and by 10% year-on-year
Key stats
What are the main financial stats of AEMD
Market
Valuations
Earnings
Shares outstanding
2.59M
Market cap
$3.44M
Enterprise value
-$1.54M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.47
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$9.34M
Net income
-$13.39M
EBIT
-$13.38M
EBITDA
-$12.76M
Free cash flow
-$7.65M
Per share
Balance sheet
Liquidity
EPS
-$8.58
EPS diluted
-$8.58
Free cash flow per share
-$4.9
Book value per share
$2.84
Revenue per share
$0
TBVPS
$4.71
Total assets
$7.36M
Total liabilities
$2.24M
Debt
$649,751
Equity
$5.12M
Working capital
$4.05M
Debt to equity
0.13
Current ratio
3.13
Quick ratio
2.97
Net debt/EBITDA
0.39
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-156.8%
Return on equity
-221.4%
Return on invested capital
-2,324%
Return on capital employed
-245%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AEMD stock price
How has the Aethlon Medical stock price performed over time
Intraday
-1.48%
1 week
3.1%
1 month
-15.29%
1 year
-55.81%
YTD
-80.67%
QTD
10.83%
Financial performance
How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.34M
Net income
-$13.39M
Gross margin
N/A
Net margin
N/A
The net income has declined by 40% since the previous quarter and by 10% year-on-year
The company's operating income rose by 26% YoY and by 4.9% QoQ
Price vs fundamentals
How does AEMD's price correlate with its fundamentals
Growth
What is Aethlon Medical's growth rate over time
Valuation
What is Aethlon Medical stock price valuation
P/E
N/A
P/B
0.47
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has surged by 78% YoY and by 32% QoQ
The P/B is 66% below the 5-year quarterly average of 1.4 and 66% below the last 4 quarters average of 1.4
The company's equity rose by 18% QoQ but it fell by 11% YoY
Efficiency
How efficient is Aethlon Medical business performance
Aethlon Medical's ROIC has plunged by 195% YoY and by 120% from the previous quarter
The ROE has plunged by 67% YoY and by 44% from the previous quarter
The ROA has plunged by 52% YoY and by 44% from the previous quarter
Dividends
What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AEMD.
Financial health
How did Aethlon Medical financials performed over time
The company's total assets rose by 13% QoQ but it fell by 11% YoY
Aethlon Medical's current ratio has increased by 12% QoQ but it has decreased by 8% YoY
The company's debt is 87% lower than its equity
The company's debt fell by 31% YoY and by 10% QoQ
The debt to equity has declined by 24% since the previous quarter and by 19% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.